Daniel Duncan

1.1k total citations
29 papers, 364 citations indexed

About

Daniel Duncan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Daniel Duncan has authored 29 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Daniel Duncan's work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (6 papers) and Acute Myeloid Leukemia Research (4 papers). Daniel Duncan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (6 papers) and Acute Myeloid Leukemia Research (4 papers). Daniel Duncan collaborates with scholars based in United States, United Kingdom and Nepal. Daniel Duncan's co-authors include Eric A. Severson, Fernando Navarrete, Leonardo De La Fuente, Paul A. Cobine, Shakti Ramkissoon, Jeffrey S. Ross, Jo‐Anne Vergilio, Douglas I. Lin, Ibrahim Ramzy and Richard S.P. Huang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Daniel Duncan

26 papers receiving 355 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Daniel Duncan 97 87 78 67 65 29 364
A. Skopelitou 68 0.7× 51 0.6× 104 1.3× 23 0.3× 42 0.6× 32 389
Tomoyuki Shirase 40 0.4× 82 0.9× 173 2.2× 37 0.6× 36 0.6× 32 436
Yiyao Deng 46 0.5× 53 0.6× 166 2.1× 26 0.4× 31 0.5× 20 436
Weiguo Lü 169 1.7× 53 0.6× 133 1.7× 75 1.1× 35 0.5× 25 403
Alexandros Papalambros 161 1.7× 99 1.1× 90 1.2× 70 1.0× 38 0.6× 25 402
Liu Zh 41 0.4× 66 0.8× 158 2.0× 113 1.7× 25 0.4× 41 350
Jarosław Piszcz 74 0.8× 63 0.7× 95 1.2× 21 0.3× 95 1.5× 49 454
Bingyin Shi 40 0.4× 23 0.3× 146 1.9× 56 0.8× 103 1.6× 34 492
Josephine Chou 100 1.0× 29 0.3× 246 3.2× 92 1.4× 25 0.4× 24 640
R. C. Horns 176 1.8× 57 0.7× 159 2.0× 65 1.0× 21 0.3× 11 411

Countries citing papers authored by Daniel Duncan

Since Specialization
Citations

This map shows the geographic impact of Daniel Duncan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Duncan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Duncan more than expected).

Fields of papers citing papers by Daniel Duncan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Duncan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Duncan. The network helps show where Daniel Duncan may publish in the future.

Co-authorship network of co-authors of Daniel Duncan

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Duncan. A scholar is included among the top collaborators of Daniel Duncan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Duncan. Daniel Duncan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duncan, Daniel, Douglas I. Lin, Richard Davis, et al.. (2023). Predicting EGFR mutational status from pathology images using a real-world dataset. Scientific Reports. 13(1). 4404–4404. 16 indexed citations
2.
Johnson, Steven M., James Haberberger, Jonathan Galeotti, et al.. (2023). Comprehensive genomic profiling reveals molecular subsets of ASXL1 -mutated myeloid neoplasms. Leukemia & lymphoma. 65(2). 209–218. 1 indexed citations
3.
Ebot, Ericka M., Daniel Duncan, Khaled Tolba, et al.. (2022). Deletions on 9p21 are associated with worse outcomes after anti-PD-1/PD-L1 monotherapy but not chemoimmunotherapy. npj Precision Oncology. 6(1). 44–44. 15 indexed citations
4.
Huang, Richard S.P., James Haberberger, Karthikeyan Murugesan, et al.. (2021). Clinicopathologic and genomic characterization of PD-L1-positive uterine cervical carcinoma. Modern Pathology. 34(7). 1425–1433. 24 indexed citations
5.
Johnson, Steven M., Lori Ramkissoon, James Haberberger, et al.. (2021). Comprehensive Genomic Characterization of ASXL1 C.1934dupG (p.G646fs*12) Versus Other ASXL1 mutations in Myeloid Neoplasia. Blood. 138(Supplement 1). 3466–3466.
6.
Huang, Richard S.P., James Haberberger, Eric A. Severson, et al.. (2021). Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial Carcinomas. The Oncologist. 26(5). 375–382. 9 indexed citations
7.
Huang, Richard S.P., Dean C. Pavlick, Lei Yang, et al.. (2021). Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12 139 Cancer Patients. Clinical Chemistry. 67(11). 1554–1566. 12 indexed citations
8.
Fitzpatrick, Megan J., Lucas R. Massoth, Jo‐Anne Vergilio, et al.. (2021). JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology. The American Journal of Surgical Pathology. 45(7). 895–904. 36 indexed citations
9.
Sokol, Ethan S., Natalie Danziger, Dean C. Pavlick, et al.. (2020). 107P Immune Checkpoint Inhibitor (ICPI) resistance genes STK11 and KEAP1: A comparative Comprehensive Genomic Profiling (CGP) study. Annals of Oncology. 31. S283–S284.
10.
Lin, Douglas I., Amanda Hemmerich, Claire Edgerly, et al.. (2020). Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss. Gynecologic Oncology. 157(2). 357–366. 40 indexed citations
11.
Hemmerich, Amanda, Claire Edgerly, Daniel Duncan, et al.. (2020). PD-L1 expression, tumor mutational burden, and microsatellite instability status in 746 pancreas ductal adenocarcinomas.. Journal of Clinical Oncology. 38(4_suppl). 757–757. 2 indexed citations
12.
Sokol, Ethan S., Natalie Danziger, Dean C. Pavlick, et al.. (2020). Clinically aggressive malignancies associated with STK11 germline mutations (STK11GCa): A comprehensive genomic profiling (CGP) study.. Journal of Clinical Oncology. 38(15_suppl). 3558–3558. 2 indexed citations
13.
Massoth, Lucas R., Yin P. Hung, Judith A. Ferry, et al.. (2019). Comprehensive Genomic Profiling of 104 Rare Histiocytic and Dendritic Cell Neoplasms Reveals Shared and Distinct Targetable Genomic Alterations. Blood. 134(Supplement_1). 2541–2541. 2 indexed citations
14.
Duncan, Daniel, Joshua F. Zeidner, & Nathan D. Montgomery. (2019). Assessing Measurable Residual Disease in Acute Myeloid Leukemia. 2(1). 45–58. 1 indexed citations
15.
Severson, Eric A., Ethan Sokol, Russell W. Madison, et al.. (2019). Loss of Heterozygosity of FLT3-ITD Is Common in Acute Myeloid Leukemia and May be a More Consistent Prognostic Marker Than FLT3-ITD Allele Frequency. Blood. 134(Supplement_1). 1437–1437. 1 indexed citations
16.
Treece, Amanda L., Daniel Duncan, Weihua Tang, et al.. (2016). Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns. Laboratory Investigation. 96(6). 661–671. 41 indexed citations
17.
Cobine, Paul A., et al.. (2013). Xylella fastidiosa Differentially Accumulates Mineral Elements in Biofilm and Planktonic Cells. PLoS ONE. 8(1). e54936–e54936. 58 indexed citations
18.
Duncan, Daniel, et al.. (2012). Displaced Granulosa Cells in the Fallopian Tube Mistaken for Metastatic Granulosa Cell Tumor. International Journal of Gynecological Pathology. 32(1). 35–37. 6 indexed citations
19.
Cotten, Steven W., et al.. (2012). Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay. Clinical Biochemistry. 45(9). 605–609. 25 indexed citations
20.
Duncan, Daniel, et al.. (1955). Argentaffin Carcinoma of Ileum with Raised Serum 5-Hydroxytryptamine. BMJ. 2(4956). 1586–1589. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Skopelitou Breakdown of academic impact, for papers by Tomoyuki Shirase Breakdown of academic impact, for papers by Yiyao Deng Breakdown of academic impact, for papers by Weiguo Lü Breakdown of academic impact, for papers by Alexandros Papalambros Breakdown of academic impact, for papers by Liu Zh Breakdown of academic impact, for papers by Jarosław Piszcz Breakdown of academic impact, for papers by Bingyin Shi Breakdown of academic impact, for papers by Josephine Chou Breakdown of academic impact, for papers by R. C. Horns
Rankless by CCL
2026